Cornercap Investment Counsel Inc. Buys 5,088 Shares of John Wiley & Sons, Inc. (NYSE:WLY)

Cornercap Investment Counsel Inc. boosted its stake in shares of John Wiley & Sons, Inc. (NYSE:WLY) by 19.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,610 shares of the company’s stock after acquiring an additional 5,088 shares during the quarter. Cornercap Investment Counsel Inc.’s holdings in John Wiley & Sons were worth $972,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. grew its stake in shares of John Wiley & Sons by 38.0% during the second quarter. BlackRock Inc. now owns 6,932,640 shares of the company’s stock valued at $235,918,000 after buying an additional 1,909,145 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of John Wiley & Sons by 2.3% during the third quarter. Vanguard Group Inc. now owns 5,466,223 shares of the company’s stock valued at $203,180,000 after buying an additional 123,637 shares during the last quarter. State Street Corp bought a new position in shares of John Wiley & Sons during the third quarter valued at approximately $174,063,000. Dimensional Fund Advisors LP grew its stake in shares of John Wiley & Sons by 7.4% during the first quarter. Dimensional Fund Advisors LP now owns 1,620,291 shares of the company’s stock valued at $62,818,000 after buying an additional 111,954 shares during the last quarter. Finally, Schroder Investment Management Group grew its stake in shares of John Wiley & Sons by 66.7% during the third quarter. Schroder Investment Management Group now owns 1,099,511 shares of the company’s stock valued at $40,869,000 after buying an additional 439,837 shares during the last quarter. 73.94% of the stock is owned by institutional investors.

John Wiley & Sons Stock Performance

WLY opened at $37.02 on Tuesday. The stock’s 50 day moving average price is $35.83 and its 200-day moving average price is $33.21. John Wiley & Sons, Inc. has a one year low of $28.83 and a one year high of $40.23. The company has a quick ratio of 0.50, a current ratio of 0.54 and a debt-to-equity ratio of 1.20.

John Wiley & Sons (NYSE:WLY) last released its earnings results on Thursday, March 7th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.14. The firm had revenue of $460.70 million for the quarter, compared to analysts’ expectations of $392.60 million. John Wiley & Sons had a positive return on equity of 18.83% and a negative net margin of 8.14%. The company’s quarterly revenue was down 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.85 earnings per share. On average, sell-side analysts forecast that John Wiley & Sons, Inc. will post 2.55 earnings per share for the current year.

John Wiley & Sons Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 25th. Investors of record on Tuesday, April 9th will be issued a $0.35 dividend. The ex-dividend date is Monday, April 8th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 3.78%. John Wiley & Sons’s payout ratio is -48.61%.

Insider Activity at John Wiley & Sons

In related news, EVP Jay Flynn sold 6,114 shares of the business’s stock in a transaction that occurred on Wednesday, April 10th. The stock was sold at an average price of $38.82, for a total value of $237,345.48. Following the completion of the sale, the executive vice president now owns 8,069 shares in the company, valued at $313,238.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.79% of the stock is owned by company insiders.

John Wiley & Sons Profile

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.